Human IGFBP-1 Antibody, R&D Systems™

IGFBP-1

Monoclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

IGFBP1

E. coli-derived recombinant human IGFBP-1

25 μg

Primary

Detects human IGFBP-1 in ELISAs and Western blots. In Western blots, detection of recombinant mouse IGFBP-1 is observed but no cross-reactivity with recombinant human (rh) IGFBP-2, rhIGFBP-3, rhIGFBP-4 or rhIGFBP-5 is observered.

Human

Purified

Western Blot, Neutralization, ELISA

33627

Western Blot 1 ug/mL, Neutralization 10-40 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL

alpha-pregnancy-associated endometrial globulin, amniotic fluid binding protein, binding protein-25, binding protein-26, binding protein-28, growth hormone independent-binding protein, hIGFBP-1, IBP1, IBP-1, IGF-binding protein 1, IGFBP1, IGFBP-1, IGF-BP25, insulin-like growth factor binding protein 1, insulin-like growth factor-binding protein 1, Placental protein 12, PP12AFBP

Mouse

Protein A or G purified from ascites

RUO

3484

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1